PARP-1

Zulfa Khan1, Anish Gomatam1, Upadhyayula Suryanarayana Murty1

  • 1Department of Medicinal Chemistry, National Institute of Pharmaceutical Education and Research, (NIPER Guwahati), Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, Govt. of India, Sila Katamur (Halugurisuk), P.O.: Changsari, Dist: Kamrup, Guwahati, Assam, 781101, India.

概括

研究人员确定了与BRCA1/2-突变乳腺癌和卵巢癌中Olaparib耐药性相关的新基因特征. 这些发现提供了克服治疗耐药性的潜在生物标志物.